Epilepsy: Quality of Life and Cost of Care

Epilepsy and Behavior

Volumn 1, Issue 2, 2000, Pages 120-127

  Schachter, Steven C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Epilepsy; quality of life; cost; seizure; health care utilization

Indexed keywords

EID: 0039592888     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1006/ebeh.2000.0049     Document Type: Review

References (74)

1. Tettenborn B, Krämer G. Total patient care in epilepsy. Epilepsia. 33:1992;S28-32.
2. Schachter S C. Advances in the assessment of refractory epilepsy. Epilepsia. 34:1993;S24-30.
3. van Hout B, Gagnon D, Souêtre E. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom. Epilepsia. 38:1997;1221-1226.
4. Harrison R M, Taylor D C. Childhood seizures: a 25-year follow up. Social and medical prognosis. Lancet. 1:1976;948-951.
5. Schachter S C, Shafer P O, Murphy W. The personal impact of seizures: correlations with seizure frequency, employment, cost of medical care, and satisfaction with physician care. J Epilepsy. 6:1993;224-227.
6. Hauser W A, Hesdorffer D C. Epilepsy: Frequency, causes and consequences. 1990;Demos, New York. p. 1-51.
7. Devinsky O, Yerby M S. Women with epilepsy: reproduction and effects of pregnancy on epilepsy. Neurol Clin. 12:1994;479-495.
8. Yerby M S. Pregnancy and epilepsy. Epilepsia. 32:1991;S51-9.
9. Loiseau J, Loiseau P, Duché B. A survey of epileptic disorders in southwest France: seizures in elderly patients. Ann Neurol. 27:1990;232-237.
10. Hauser W A. Seizure disorders: the changes with age. Epilepsia. 33:1992;S6-14.
11. Epilepsia. 30:1989;389-399.
12. Schachter S C. Update in the treatment of epilepsy. Compr Ther. 21:1995;473-479.
13. Schachter, S, C. Brainstorms: epilepsy in our words. New York, Raven Press, 1993; 9-83.
14. Elwes R DC, Johnson A L, Shorvon S D. The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med. 311:1984;944-947.
15. Baker G A, Gagnon D, McNulty P. The relationship between seizure frequency, seizure type and quality of life: findings from three European countries. Epilepsy Res. 30:1998;231-240.
16. Jacoby A, Baker G A, Steen N. The clinical course of epilepsy and its psychosocial correlates: findings from a UK community study. Epilepsia. 37:1996;148-161.
17. Mattson R H, Cramer J A, Collins J F. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med. 327:1992;765-771.
18. Mattson R H, Cramer J A, Collins J F. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med. 313:1985;145-151.
19. Leppik I E. How to get patients with epilepsy to take their medication: the problem of noncompliance. Postgrad Med. 88:1990;253-256.
20. Baker G A, Nashef L, van Hout B A. Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality. Epilepsia. 38:1997;S1-8.
21. Helgeson D C, Mittan R, Tan S Y. Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia. 31:1990;75-82.
22. Buck D, Jacoby A, Baker G A. Patients' experiences of and satisfaction with care for their epilepsy. Epilepsia. 37:1996;841-849.
23. Andermann L F. Epilepsy in developing countries. Transcult Psychiatr Res Rev. 32:1995;351-384.
24. Betts T, Smith K. New departures in epilepsy care: an epilepsy liaison service. Seizure. 3:1994;301-308.
25. Dilorio C, Faherty B, Manteuffel B. Epilepsy self-management: partial replication and extension. Res Nurs Health. 17:1994;167-174.
26. Rousseau A, Hermann B, Whitman S. Effects of progressive relaxation on epilepsy: analysis of a series of cases. Psychol Rep. 57:1985;1203-1212.
27. Tozzo C A, Elfner L F, May J G Jr. EEG biofeedback and relaxation training in the control of epileptic seizures. Int J Psychophysiol. 6:1988;185-194.
28. Goldstein L H. Behavioural and cognitive-behavioural treatments for epilepsy: a progress review. Br J Clin Psychol. 29:1990;257-269.
29. Legion V. Health education for self-management by people with epilepsy. J Neurosci Nurs. 23:1991;300-305.
30. Finelli P F, Cardi J K. Seizure as a cause of fracture. Neurology. 39:1989;858-860.
31. Annegers J F, Melton L J 3rd, Sun C-A. Risk of age-related fractures in patients with unprovoked seizures. Epilepsia. 30:1989;348-355.
32. Spitz M C, Towbin J A, Shantz D. Risk factors for burns as a consequence of seizures in persons with epilepsy. Epilepsia. 35:1994;764-767.
33. Kirby S, Sadler R M. Injury and death as a result of seizures. Epilepsia. 36:1995;25-28.
34. Derby L E, Tennis P, Jick H. Sudden unexplained death among subjects with refractory epilepsy. Epilepsia. 37:1996;931-935.
35. Jones M W. Consequences of epilepsy: why do we treat seizures? Can J Neurol Sci. 25:1998;S24-6.
36. Engel J Jr. Surgery for seizures. N Engl J Med. 334:1996;647-652.
37. Markowitz M A, Mauskopf J A, Halpern M T. Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy. Neurology. 51:1998;1026-1033.
38. Schachter S C, Sommerville K W, Ryan J E. A cost-effectiveness analysis of tiagabine, phenytoin, and carbamazepine adjunctive therapy for patients with complex partial seizures. Epilepsy Res. 29:2000.
39. Heaney D C, Shorvon S D, Sander J W. An economic appraisal of carbamazepine, lamotrigine, phenytoin and valproate as initial treatment in adults with newly diagnosed epilepsy. Epilepsia. 39:1998;S19-25.
40. Malmgren K, Hedström A, Granqvist R. Cost analysis of epilepsy surgery and of vigabatrin treatment in patients with refractory partial epilepsy. Epilepsy Res. 25:1996;199-207.
41. King J T, Sperling M R, Justice A C. A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy. J Neurosurg. 87:1997;20-28.
42. Langfitt J T. Cost-effectiveness of anterotemporal lobectomy in medically intractable complex partial epilepsy. Epilepsia. 38:1997;154-163.
43. Yagi K. Epilepsy: comprehensive care, quality of life, and factors preventing people with epilepsy from being employed. Clin Ther. 20:1998;A19-29.
44. Kellett M W, Smith D F, Baker G A. Quality of life after epilepsy surgery. J Neurol Neurosurg Psychiatry. 63:1997;52-58.
45. Cooper M. Epilepsy and employment - employers' attitudes. Seizure. 4:1995;193-199.
46. Sillanpaa M, Jalava M, Kaleva O, Shinnar S. Long-term prognosis of seizures with onset in childhood. N Engl J Med. 338:1998;1715-1722.
47. Devinsky O, Vickrey B G, Cramer J. Development of the Quality of Life in Epilepsy Inventory. Epilepsia. 36:1995;1089-1104.
48. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia. 38:1997;233-236.
49. Cramer J A, Perrine K, Devinsky O. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia. 39:1998;81-88.
50. Cramer J A, Perrine K, Devinsky O. A brief questionnaire to screen for quality of life in epilepsy: The QOLIE-10. Epilepsia. 37:1996;577-582.
51. Vickrey B G, Hays R D, Graber J. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care. 30:1992;299-319.
52. Baker G A, Smith D F, Dewey M. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res. 16:1993;65-81.
53. Cramer J A. A clinimetric approach to assessing quality of life in epilepsy. Epilepsia. 34:1993;S8-13.
54. Leidy N K, Rentz A M, Grace E M. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy. Epilepsia. 39:1998;965-977.
55. Langfitt J T. Comparison of the psychometric characteristics of three quality of life measures in intractable epilepsy. Qual Life Res. 4:1995;101-114.
56. Dodrill C B, Batzel L W, Queisser H R. An objective method for the assessment of psychological and social problems among epileptics. Epilepsia. 21:1980;123-135.
57. Batzel L W, Dodrill C B, Dubinsky B L. An objective method for the assessment of psychosocial problems in adolescents with epilepsy. Epilepsia. 32:1991;202-211.
58. Wiebe S, Rose K, Derry P. Outcome assessment in epilepsy: Comparative responsiveness of quality of life and psychosocial instruments. Epilepsia. 38:1997;430-438.
59. Bruni J. Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice. Can J Neurol Sci. 25:1998;134-140.
60. Dodrill C B, Arnett J L, Sommerville K W. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology. 48:1997;1025-1031.
61. Smith D F, Baker G A, Davies G. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia. 34:1993;312-322.
62. Mortimore C, Trimble M, Emmers E. Effects of gabapentin on cognition and quality of life in patients with epilepsy. Seizure. 7:1998;359-364.
63. Vickrey B G, Hays R D, Engel J Jr. Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann Neurol. 37:1995;158-166.
64. McLachlan R S, Rose K J, Derry P A. Health-related quality of life and seizure control in temporal lobe epilepsy. Ann Neurol. 41:1997;482-489.
65. Malmgren K, Sullivan M, Ekstedt G. Health-related quality of life after epilepsy surgery: a Swedish multicenter study. Epilepsia. 38:1997;830-838.
66. Rapp S, Shumaker S, Smith T. Adaptation and evaluation of the Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients. Qual Life Res. 7:1998;467-477.
67. Griffiths R I, Schrammel P N, Morris G L. Payer costs of patients diagnosed with epilepsy. Epilepsia. 40:1999;351-358.
68. Begley C E, Annegers J F, Lairson D R. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia. 35:1994;1230-1243.
69. Pachlatko C. The cost of epilepsy care to the community. Seizure. 6:1997;415-417.
70. Currie C J, Morgan C L, Peters J R. The demand for hospital services for patients with epilepsy. Epilepsia. 39:1998;537-544.
71. Murray M I, Halpern M T, Leppik I E. Cost of refractory epilepsy in adults in the USA. Epilepsy Res. 23:1996;139-148.
72. Jacoby A, Buck D, Baker G. Uptake and costs of care for epilepsy: findings from a U.K. regional study. Epilepsia. 39:1998;776-786.
73. Begley C E, Annegers J F, Lairson D R. Methodological issues in estimating the cost of epilepsy. Epilepsy Res. 33:1999;39-55.
74. Beran R G, Pachlatko C. Final report of the ILAE Commission on Economic Aspects of Epilepsy, 1994-1997. Epilepsia. 38:1997;1359-1362.